Correlation Between Oncology Pharma and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Oncology Pharma and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncology Pharma and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncology Pharma and MAIA Biotechnology, you can compare the effects of market volatilities on Oncology Pharma and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncology Pharma with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncology Pharma and MAIA Biotechnology.
Diversification Opportunities for Oncology Pharma and MAIA Biotechnology
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Oncology and MAIA is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Oncology Pharma and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Oncology Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncology Pharma are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Oncology Pharma i.e., Oncology Pharma and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Oncology Pharma and MAIA Biotechnology
Given the investment horizon of 90 days Oncology Pharma is expected to generate 47.93 times more return on investment than MAIA Biotechnology. However, Oncology Pharma is 47.93 times more volatile than MAIA Biotechnology. It trades about 0.34 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about 0.04 per unit of risk. If you would invest 2.50 in Oncology Pharma on September 3, 2024 and sell it today you would lose (2.49) from holding Oncology Pharma or give up 99.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 70.65% |
| Values | Daily Returns |
Oncology Pharma vs. MAIA Biotechnology
Performance |
| Timeline |
| Oncology Pharma |
| MAIA Biotechnology |
Oncology Pharma and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncology Pharma and MAIA Biotechnology
The main advantage of trading using opposite Oncology Pharma and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncology Pharma position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Oncology Pharma vs. Regen BioPharma | Oncology Pharma vs. Regen BioPharma | Oncology Pharma vs. Therapeutic Solutions International | Oncology Pharma vs. Alpha Cognition |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |